News

Published on 17 Jan 2022 on Motley Fool

3 Unstoppable Stocks That Can Beat Bitcoin in 2022


Article preview image

Bitcoin (CRYPTO: BTC) delivered its worst performance in 2021 of the past three years. Here are three unstoppable stocks, in particular, that can beat...

NYSE.IIPR price evolution
NASDAQ.VTRS price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Viatris Inc's Dividend Analysis

Assessing the Sustainability of Viatris Inc's Dividend Payments Viatris Inc (NASDAQ:VTRS) recentl...

GuruFocus.com via Yahoo Finance 8 Mar 2024

Insider Sell: President of Greater China Xiangyang Ni Sells 21,532 Shares of Viatris Inc (VTRS)

Xiangyang Ni, President of Greater China at Viatris Inc (NASDAQ:VTRS), executed a sale of 21,532 ...

GuruFocus.com via Yahoo Finance 5 Mar 2024

Viatris Inc. (NASDAQ:VTRS) Q4 2023 Earnings Call Transcript

Viatris Inc. (NASDAQ:VTRS) Q4 2023 Earnings Call Transcript February 28, 2024 Viatris Inc. misses...

Insider Monkey via Yahoo Finance 5 Mar 2024

13 Best Pharma Dividend Stocks To Buy in 2024

In this article, we discuss 13 best pharma dividend stocks to buy in 2024. You can skip our detai...

Insider Monkey via Yahoo Finance 5 Mar 2024

Viatris' (VTRS) Generic Declines in Q4, Yupleri Sales Rise

Shares of Viatris, Inc. VTRS lost 4.8% in the last three trading sessions after the company repor...

Zacks via Yahoo Finance 5 Mar 2024

Revance announces $100 million stock offering By Investing.com

Revance Therapeutics, Inc. (NASDAQ: NASDAQ:RVNC), a biotechnology company, has announced a propos...

Investing.com 4 Mar 2024

Revance sets $100 million stock offering at $6.25 per share

Revance Therapeutics, Inc. ( NASDAQ : NASDAQ: RVNC ), a biotechnology firm specializing in aesthe...

Investing.com 4 Mar 2024

Revance sets $100 million stock offering at $6.25 per share

Revance Therapeutics, Inc. (NASDAQ: NASDAQ: RVNC ), a biotechnology firm specializing in aestheti...

Investing.com 3 Mar 2024

Viatris' (VTRS) Q4 Earnings and Revenues Miss Estimates

Viatris Inc. VTRS delivered adjusted earnings of 61 cents per share in the fourth quarter of 2023...

Zacks via Yahoo Finance 28 Feb 2024

Stocks Fall Ahead Of Fed's Inflation Data, UnitedHealth Sinks, Bitcoin Tops $61,000: What's Driving...

Stocks dipped modestly following a report indicating a marginal downward revision in the U.S. eco...

Benzinga 28 Feb 2024